IHC-plus(tm) LMO4 Antibody (aa115-127)

LifeSpan BioSciences

IHC-plus(tm) LMO4 Antibody (aa115-127)

23

Immunohistochemistry: LS-B2619 was validated for use in immunohistochemistry on a panel of 21 formalin-fixed, paraffin-embedded (FFPE) human tissues after heat induced antigen retrieval in pH 6.0 citrate buffer. After incubation with the primary antibody, slides were incubated with biotinylated secondary antibody, followed by alkaline phosphatase-streptavidin and chromogen. The stained slides were evaluated by a pathologist to confirm staining specificity. The optimal working concentration for LS-B2619 was determined to be 5 ug/ml.. ELISA, IHC, IHC-Fr (1:200 - 1:1000), IHC-P (5 µg/ml), WB (1:200 - 1:1000) Immunohistochemistry: LS-B2619 was validated for use in immunohistochemistry on a panel of 21 formalin-fixed, paraffin-embedded (FFPE) human tissues after heat induced antigen retrieval in pH 6.0 citrate buffer. After incubation with the primary antibody, slides were incubated with biotinylated secondary antibody, followed by alkaline phosphatase-streptavidin and chromogen. The stained slides were evaluated by a pathologist to confirm staining specificity. The optimal working concentration for LS-B2619 was determined to be 5 ug/ml.

Western Blot, ELISA, ImmunoHistoChemistry, ImmunoHistoChemistry Frozen, ImmunoHistoChemistry Paraffin

Research Use Only

Polyclonal

1 mg/ml

Unconjugated

LMO4

LIM domain only 4

LIM domain transcription factor LMO4, LIM domain only protein 4, LIM-only 4 protein, LMO-4, breast tumor autoantigen

Rabbit

IgG

Human, Rodent

2°C to 8°C or -20°C

41116161